Please upgrade your browser.
The U.S. Food & Drug Administration has approved everolimus (brand name: Afinitor) for the treatment of advanced kidney cancer. Learn more in this audio podcast.
The U.S. Food and Drug Administration today approved Afinitor oral tablets (everolimus) for the treatment of patients with advanced kidney cancer whose disease has progressed after treatment with other cancer therapies.
MSNBC asks: If you were grading Barack Obama on his performance as president, what would he get?
My husband voted for you in the election. It was the last vote for a president he would make and he knew it.
The Daily Mail reported that "cancer survival rates in Britain (are] among the worst in Europe.
Carol London, from Kings Cross, is running in this years marathon in memory of her 12-year-old daughter Saffron, who died in 2007 after developing a rare kidney cancer.
In How to Fix Medicare: Let's Pay Patients, Not Physicians, health economist Roger Feldman argues that a radical shift in Medicare policy is not only possible but imperative. Under Feldman's "medical indemnity" proposal, Medicare would pay each patient a fixed amount of money, reserving larger subsidies for sicker people. Patients, in turn, would select their own medical services from providers who would set their own competitive rates.
A type of drug designed to stunt tumour growth has actually been found to fuel cancer if given at too low a dose.
In vitro testing of darinaparsin using the National Cancer Institute's human cancer cell panel detected activity against a series of tumor cell lines including lung, colon, brain, melanoma, ovarian, and kidney cancer.
Drugmakers have to wait for patients to trickle through other medications and many patients will be sopped up by the other drugs. It's better used as a way to get your foot in the door, as Novartis (NYSE: NVS) is trying to do with Afinitor, its kidney cancer treatment for patients who have failed current treatments.
|Powered by NeonCRM|